Table 1. Parkinson’s disease participant characteristics including age, sex, clinical evaluation using the motor section of the Unified Parkinson’s Disease Rating Scale, Modified Mini Mental State Exam, Corsi Working Memory Tapping Test, current Parkinson medication, and the total number of freezing of gait episodes experienced.

Participant	Age	Sex	UPDRS-III	3MS	Corsi WMT	Medications	Dosage (mg)	FOGExperienced	Total#FOG
1	62	M	41	93	2	Sinemet	312.5	Y	20
2	65	F	31	–	–	Sinemet	125	Y	1
3	70	M	34	87	4	Sinemet	125	N	0
4	83	M	38	89	4	Sinemet	187.5	N	0
5	80	M	33	76	3	Sinemet	375	Y	8
6	78	M	27	86	4	Sinemet	312.5	Y	1
7	72	M	23	89	3	mirapex	125	Y	2
8	71	M	20	91	4	Sinemet	187.5	N	0
9	75	M	34	78	2	no meds	0	N	0
10	83	M	40	88	3	Sinemet	375	Y	10
11	77	M	35	–	–	Sinemet	125	N	0
12	59	F	25	–	–	sin/com	187.5/200	Y	2
13	73	M	29	98	4	sin/com	250/100	N	0
14	68	M	36	–	–	Sinemet	312.5	Y	1
15	82	F	40	–	–	sin/com	312.5/200	Y	32
16	78	M	49	98	6	sinemet	125	N	0
17	78	F	51	–	–	sin/mir	125	Y	37
18	79	M	32	–	–	Stalevo	125	N	0
19	78	M	36	96	5	sin/trihex	187.5	Y	39
Average	74	15M	34	89.1	3.7		195.3	11 Y	7.7